Trusted Resources: Education
Scientific literature and patient education texts
Cardiac Amyloidosis: The Great Pretender
source: Heart Failure Reviews
year: 2015
authors: Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, Salvi F, Maurer MS
summary/abstract:Cardiac amyloidosis (CA) is often misdiagnosed because of both physician-related and disease-related reasons including: fragmented knowledge among different specialties and subspecialties, shortage of centres and specialists dedicated to disease management, erroneous belief it is an incurable disease, rarity of the condition, intrinsic phenotypic heterogeneity, genotypic heterogeneity in transthyretin-related forms and the necessity of target organ tissue histological diagnosis in the vast majority of cases. Pitfalls, incorrect beliefs and deceits challenge not only the path to the diagnosis of CA but also the precise identification of aetiological subtype. The awareness of this condition is the most important prerequisite for the management of the risk of underdiagnoses and misdiagnosis.
Almost all clinical, imaging and laboratory tests can be misinterpreted, but fortunately each of these diagnostic steps can also offer diagnostic “red flags” (i.e. highly suggestive findings that can foster the correct diagnostic suspicion and facilitate early, timely diagnosis). This is especially important because outcomes in CA are largely driven by the severity of cardiac dysfunction and emerging therapies are aimed at preventing further amyloid deposition.
organization: University of Bologna, ItalyDOI: 10.1007/s10741-015-9480-0
read more
Related Content
-
Cardiac Amyloidosis Imaging With Amyloid Positron Emission Tomography: A Systematic Review and Meta-AnalysisBackground: Recent progress in amyloid ...
-
Panel Discussion/Q&A – ASG Webinar 1.25.24 – 5/9https://www.youtube.com/watch?v=A9g6r1PQ...
-
The University of Texas Southwestern Medical CenterThe University of Texas Southwestern Med...
-
Transthyretin Cardiac Amyloidosis in Black AmericansTransthyretin-related cardiac amyloidosi...
-
Amyloidosis now a hot topic in cardiac imaging due to new drug treatmentJuly 11, 2023 | Cardiovascular Business ...
-
Improving Strategies for the Diagnosis of Cardiac AmyloidosisAmyloidosis refers to a group of rare bu...
-
World Heart Day 2022World Heart Day is an opportunity for ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.